Bristol-Myers Squibb Co
NYSE:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
NYSE:BMY
Watchlist
Price: 51.95 USD 1.94% Market Closed
Market Cap: 105.8B USD

Wall Street
Price Targets

BMY Price Targets Summary
Bristol-Myers Squibb Co

Wall Street analysts forecast BMY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BMY is 53.02 USD with a low forecast of 33.43 USD and a high forecast of 71.4 USD.

Lowest
Price Target
33.43 USD
36% Downside
Average
Price Target
53.02 USD
2% Upside
Highest
Price Target
71.4 USD
37% Upside
Bristol-Myers Squibb Co Competitors:
Price Targets
002332
Zhejiang Xianju Pharmaceutical Co Ltd
30% Upside
1760
Panion & BF Biotech Inc
24% Upside
688578
Shanghai Allist Pharmaceuticals Co Ltd
23% Upside
OMER
Omeros Corp
211% Upside

Revenue
Forecast

Revenue Estimate
Bristol-Myers Squibb Co

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 7%. The projected CAGR for the next 3 years is -3%.

7%
Past Growth
-3%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bristol-Myers Squibb Co

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 4%. The projected CAGR for the next 3 years is 10%.

4%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Bristol-Myers Squibb Co

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BMY's stock price target?
Price Target
53.02 USD

According to Wall Street analysts, the average 1-year price target for BMY is 53.02 USD with a low forecast of 33.43 USD and a high forecast of 71.4 USD.

What is Bristol-Myers Squibb Co's Revenue forecast?
Projected CAGR
-3%

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 7%. The projected CAGR for the next 3 years is -3%.

What is Bristol-Myers Squibb Co's Operating Income forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 4%. The projected CAGR for the next 3 years is 10%.

Back to Top